April 2023 - Page 11 of 16

WednesdayApr 12, 2023 1:53 pm

QualityStocksNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Moving Forward with Spin-Off of Subsidiary, Value Creation Strategy

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has initiated a spin-off plan for its wholly owned subsidiary, coyni inc., a stablecoin technology. RYVYL believes the separation of coyni from its payment-processing business will provide the opportunity for each business to focus on its own strategic and operational objectives. According to the announcement, RYVYL has identified the investment banking team for the proposed transaction and is in the process of evaluating mergers with possible partners; it anticipates acquiring a vehicle in the coming weeks to…

WednesdayApr 12, 2023 1:33 pm

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Reschedules Special Meeting of Stockholders, Extends Deadline for Share Redemption

Fintech Ecosystem Development (NASDAQ: FEXD) has announced plans to adjourn the company’s special meeting of stockholders; the meeting was scheduled for today, but the company intends on reconvening the Special Meeting on Thursday, April 20, 2023, at 10 a.m. ET. The company is also extending the deadline for holders of its shares of Class A common stock to exercise their right to redeem their shares for their pro rata portion of the funds available in the company's trust account, or to withdraw any previously delivered demand for redemption; that deadline has been changed to April 18, 2023, at 5 p.m.…

WednesdayApr 12, 2023 9:45 am

Lift Toronto 2023 Cannabis Conference and Expo Announces Speakers and Sessions; Registration Now Open

Thousands of cannabis industry and community members will gather at the Metro Toronto Convention Centre, June 1-3, for three high-energy days of discovery, education, entertainment and more. The highly anticipated Lift Toronto 2023 Cannabis Conference and Expo, which will bring together thousands of cannabis industry professionals and consumers from all parts of the cannabis ecosystem, returns to the Metro Toronto Convention Centre from June 1-3, 2023. Hundreds of exhibiting companies will showcase the latest in cannabis products, services and innovations; industry leaders and fresh voices will take the stage; and new experiences and activations will lead to Lift’s signature a-ha…

WednesdayApr 12, 2023 9:00 am

SideChannel Inc. (SDCH) Offers Unique Suite of Cybersecurity and Privacy Services On An As-Needed Basis for Optimum Affordability

SideChannel is a cybersecurity services company driven by a stated mission to make cybersecurity simple, accessible, effective, and affordable The company targets small and mid-sized businesses that are often priced out of quality cybersecurity services SideChannel’s services include vCISO services, vCPO services, risk assessment, cybersecurity compliance, and third-party risk management By providing these services, the company empowers clients to reduce risks, balance their security and privacy services investment, and build the confidence needed to operate with business-aligned security and privacy SideChannel (OTCQB: SDCH), a company focused on addressing cybersecurity challenges for mid-market companies, startups, and small enterprises normally priced out…

TuesdayApr 11, 2023 4:06 pm

QualityStocksNewsBreaks – Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Intersects Broad Interval of VMS Mineralization in First Drill Hole at Western Target

Arizona Metals (TSX: AMC) (OTCQX: AZMCF) today announced that the first hole (KM-23-104) drilled at the Western Target of the Kay Mine Project intersected 16 metres of stringer to semi-massive sulphide mineralization, including visible copper sulphide (chalcopyrite) and zinc sulphide (sphalerite). According to the update, the VMS mineralization occurs within a broader interval of syn-mineral quartz-carbonate veining accompanied by sulphide minerals (pyrite, pyrrhotite, sphalerite, chalcopyrite, and arsenopyrite) and anomalous zinc and copper readings from onsite portable XRF. The hole ended in sulphide-bearing core but was stopped at 888 metres downhole due to separated drill rods. Hole 104 was submitted for…

TuesdayApr 11, 2023 12:10 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Secures Another Contract Win from Leading Fintech Giant

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced an additional contract win from one of its largest fintech clients. The client, a leading global organization providing merchant, banking and capital market solutions marketplaces, processes over 75 billion transactions amounting to more than $9 trillion annually. Data 443 has been a trusted partner for the client’s enterprise file transfer service requirements for more than 15 years. Data443’s Data Placement Manager processes thousands of sensitive data files per hour for thousands of partners around the globe, and the company’s platform continues significant focus…

TuesdayApr 11, 2023 10:30 am

GeoSolar Technologies Inc. Advances Home Renewable Systems That Reduce Carbon Use and Potentially Eliminate Utility Bills

GeoSolar’s SmartGreen(TM) whole-home renewable energy system potentially reduces dependence on fossil fuels while lowering or even completely eliminating utility bills The SmartGreen(TM) system includes photovoltaic solar panels, geothermal ground loops, integrated air ducts and floor loops, CERV(R) air filtration, upgrades to lighting systems, windows, insulation The SmartGreen(TM) system can be integrated into new construction projects or existing buildings GeoSolar plans to market SmartGreen(TM) to over 120 million homes across the U.S. with various financing options, tax deductions, utility incentives The Intergovernmental Panel on Climate Change (“IPCC”) has stated that there is over a 95% probability that the observed warming of…

TuesdayApr 11, 2023 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues

CNS Pharmaceuticals recently announced it had enrolled the first patient in Switzerland as part of its ongoing potentially pivotal global GBM trial The adaptive, multicenter, open-label, randomized controlled trial is evaluating Berubicin for the treatment of recurrent GBM, the most common primary brain cancer, compared to Lomustine, the current standard of care The enrollment moves the company closer to its goal of undertaking an interim analysis expected in the third quarter of 2023 So far, CNS Pharmaceuticals has opened over 40 of 59 planned clinical trial sites selected across Switzerland, Spain, France, Italy, and the U.S. As an aside, the…

TuesdayApr 11, 2023 9:00 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Is ‘One to Watch’

Reflex Advanced Materials has begun the qualification process and boasts established relationships with more than 25 key North American customers, putting it years ahead of the competition in the lengthy graphite sales cycle. The company has a planned summer 2023 drill program at the Ruby Graphite project in Montana. Reflex Advanced Materials has entered a metallurgical partnership with AETC to create a technical data sheet on Ruby Graphite material. The company has executed two critical product development and material research partnerships in an effort to diversify risk and improve margins. The U.S. Department of Energy is in the process of…

MondayApr 10, 2023 1:13 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that more than 100 patients have been enrolled in the company’s potentially pivotal study with its lead product candidate, Berubicin. “We have long promised a study with a robust sample size sufficient to effectively determine Berubicin’s therapeutic potential,” said John Climaco, CEO of CNS Pharmaceuticals. “Today’s achievement shows we are doing just that. Enrolling over 100 patients in this relatively rare disease in a little more than 18 months is a remarkable…

Site Search

Company Search

Month: April 2023